myRocky Tirzepatide Review: Mounjaro and Separate Care Fees

myRocky's body-optimization page offers a branded Mounjaro pathway with a $99 initial consultation, followed by a $99 monthly program fee plus medication. The consultation price is not a tirzepatide supply, and the monthly program fee is not the complete ongoing treatment cost.¹

Our view: compare myRocky as a care-and-prescribing arrangement with a separate pharmacy price. The reviewed page refers to licensed US providers; do not assume that pricing from a similarly named service in another country applies. Exact state eligibility, pharmacy details and the individual medication quote still need confirmation.

What the two $99 charges represent

The page lists $99 for the initial consultation and says medication plus a $99 program fee is charged monthly. The program fee includes clinician access, new prescriptions and pharmacy counseling. It describes labs before prescribing and allows recent results to be supplied when appropriate.¹

Ask whether the initial and recurring fees can fall in the same billing period and when ongoing billing begins. Also establish whether lab testing is included or paid separately. A service can present a clear consultation price while the total first month remains substantially different.

The medication quote should name Mounjaro, the device, prescribed dose, supply period and dispensing pharmacy. If insurance is involved, ask whether the charge reflects a confirmed benefit or an estimate. myRocky's page says patients should contact their insurer and can request an invoice; an invoice does not guarantee reimbursement.¹

For a related approved tirzepatide cost comparison, consult our Zepbound cost guide. Keep product and indication separate: Zepbound and Mounjaro contain tirzepatide but should not be treated as interchangeable insurance claims or savings offers.

What the clinical pathway looks like

myRocky describes an initial online assessment, clinician review, lab testing or recent-result review, a prescription if appropriate and ongoing access to the clinician and pharmacy team. Those steps establish a care pathway, not a guarantee that every applicant receives Mounjaro.¹

Before paying, ask who reviews your information, whether a live visit may be required and how to communicate between appointments. Find out what follow-up is expected before a refill and whether the monthly fee continues when treatment is paused. A useful program should explain the service you receive even in a month without a new prescription.

Mounjaro should be identified as a branded product

The reviewed pathway names Mounjaro. A consumer should know whether the actual proposed order is that brand rather than a compounded preparation. Ask for the precise product in the quote and on the prescription, especially if several medication options are discussed.

Our Zepbound injection guide illustrates why the actual device should be identified before discussing technique. Ask the pharmacist to explain the instructions for the Mounjaro product dispensed to you.

The clinician should explain the indication and whether a proposed prescription is on-label or off-label. Insurance and savings eligibility can depend on that context. A marketing category such as body optimization should not replace a clear medical explanation of the actual prescription.

Pharmacy, location and delivery need individual confirmation

The reviewed pages do not independently establish the pharmacy facility or a reliable complete state list. Ask for eligibility in the state where you will receive care and for the dispensing pharmacy's identity. A US-provider statement is not proof of access in every state.

Delivery descriptions should also be read as part of the full process. An estimated shipping time generally follows the necessary assessment and prescription; it should not be treated as the elapsed time from paying the consultation to receiving medication. Ask how delays, pharmacy questions and tracking updates are handled.

If the quoted pharmacy changes, request an updated product and price summary before accepting a substitution. A recognizable platform name does not eliminate the need to understand the actual pharmacy purchase.

The money-back claim has a limited scope

The treatment page advertises a progress-related promise involving consultation costs. It should not be understood as an unconditional refund of medication spending or all program fees. Prior monthly fees have refund limits.¹²

Ask for the applicable guarantee conditions, required participation, time period and excluded costs. Separately obtain cancellation instructions and the next billing date. Ending future care and receiving money back for past services are different outcomes.

Where myRocky fits

myRocky may suit a reader who wants online clinician access and a branded Mounjaro discussion while paying separately for medication. Its strengths are identified clinical fees and a described assessment pathway. Its limits are the missing final pharmacy cost, unverified individual access details and qualified refund promise.

Our Ro review provides another model of care fees alongside a separate medication purchase. Compare what ongoing access actually includes, how prescriptions are reviewed and the total cost under your own coverage. The two $99 figures are only the start of that comparison.

The JM Integrated Health review also keeps enrollment and ongoing care separate from medication. The ZipHealth review instead examines a clinical fee attached to new and repeat prescriptions.